SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.

CONCLUSION: Treatment with 12 SQ-HDM consistently improved symptoms and was well tolerated in relevant subgroups of subjects with HDM AR/C. Local application site reactions to 12 SQ-HDM were typically mild-to-moderate and transient. PMID: 29656145 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29656145?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - April 12, 2018 Category: Allergy & Immunology Authors: Bernstein DI, Kleine-Tebbe J, Nelson HS, Bardelas JA, Sussman GL, Lu S, Rehm D, Fogh BS, Nolte H Tags: Ann Allergy Asthma Immunol Source Type: research